Bloom Energy's Billion-Dollar Quarter Masks a Brutal Tug-of-War Over the Stock's Future

Bloom Energy posts record Q2 revenue and profit, raises guidance, yet shares lag amid short-seller allegations and insider sales.

The fuel-cell maker just posted numbers that would make most chief executives giddy — record revenue, a swing to net profit, and a guidance raise delivered twice in quick succession. Yet the shares remain roughly 42% below their June peak, and the gap between operational momentum and market skepticism has rarely looked wider.

A Quarter That Reset the Bar

Bloom Energy's second-quarter results landed with force. Revenue hit $1.07 billion, a jump of roughly 166% year over year, while product revenue alone surged to $935.4 million — more than triple the prior-year figure. Adjusted earnings per share came in at $0.78, up from $0.10 a year earlier and nearly double the $0.39 consensus. The company also generated $226.4 million in operating cash flow and posted net income of $196.3 million, a stark reversal from the loss it recorded in the same period last year.

Management responded by lifting its full-year 2026 outlook for the second time, now calling for revenue between $3.9 billion and $4.2 billion — up from the prior range of $3.4 billion to $3.8 billion — with EPS expected between $2.55 and $2.85. For context, 2025 revenue came in at $2.02 billion, a 37% increase.

CEO KR Sridhar said every major US hyperscaler, along with more than a dozen neoclouds, AI labs, and colocation data centers, has now validated the company's technology. That demand backdrop has fueled ambitious projections: an analyst at The Motley Fool, Daniel Sparks, calculates Bloom could double revenue again by the end of 2029, reaching roughly $8.1 billion — implying annual growth of about 26%. To keep pace, the company is expanding its Fremont manufacturing capacity from one to two gigawatts by the end of 2026, at a cost of $100 million to $150 million per gigawatt. Cash on hand stood at $2.67 billion.

The Short-Seller Cloud

The stock initially popped around 12% on the earnings news, and Friday's close in Germany at €178.80 marked a weekly gain of nearly 10%. But the rally hasn't dispelled the doubts that have been weighing on the shares.

Hunterbrook Media published an investigation alleging Bloom Energy's heavy reliance on Chinese scandium could jeopardize its goal of producing five gigawatts annually. The company fired back, calling the report false and misleading, pointing to its audited financials and explicitly disputing the claims about its scandium oxide supply chain. Crossroads Capital has also disclosed a short position, betting on a downward correction. For now, it's a war of press releases — no independent verdict has emerged.

Adding to the overhang: a securities fraud class action covering the period from February 27, 2025, through July 8, 2026, with the lead plaintiff deadline set for late September. Meanwhile, several insiders, including Shawn Marie Soderberg and Maciej Kurzymski, sold share packages in May at prices around $290.

Bulls, Bears, and a Split Analyst Ranks

The analyst community remains divided. Mizuho upgraded the stock to Outperform with a $242 price target following the sell-off. Roth Capital, Barclays, and Evercore sit at $285, $276, and $350 respectively, while Wells Fargo trimmed its target to $176. The consensus sits at Moderate Buy, though the average target differs depending on the source: $246.18 in dollar terms or €237.08 — implying roughly 32.6% upside from Friday's close but still well below the June high of €308.50.

Nine analysts rate the stock a Buy against ten Holds. RBC Capital advises using the weakness as an entry point. The bulls also note the shares trade nearly 20% above their 200-day moving average of €149.27, suggesting the long-term uptrend remains intact despite the correction.

The bears counter with concentration risk. Key projects with Oracle and AEP have slipped significantly, which could pressure estimates for 2027 and 2028. TD Cowen argues the stock is already fully valued given AI-driven volatility and a shifting investor base, with Bloom ranking among the most expensive names by price-to-book. Technical indicators add to the caution: annualized 30-day volatility sits at an extreme 141.44%, while the 14-day RSI at 44.4 signals no clear direction.

The Institutional Picture

Institutional ownership stands at 77.04%, but the recent filings show mixed signals. The California State Teachers Retirement System trimmed its position by 2.4% in the first quarter, though it still holds shares worth roughly $42.1 million. Over the past 30 trading days, the stock has shed 29.74% — a reminder that even strong fundamentals haven't shielded investors from sharp pullbacks following the earlier run-up.

The path forward hinges on execution. If Bloom can convert its order backlog into cash-generating revenue at the pace of the latest quarter, the consensus target of €237.08 — and potentially the June high of €308.50 — remains within reach. Further delays on the Oracle or AEP projects, or an escalation of the scandium dispute beyond the current exchange of statements, could send the shares back toward the 200-day average. The next test comes when management must prove it can deliver on the freshly raised guidance in the quarters ahead. Until then, expect every short-seller report and project timeline update to move the needle — in either direction.